How to buy Botox wholesale safely: authorized channels and red flags

Updated September 2026. Product list and FDA sources checked as of September 23, 2026.

Short answer: To buy Botox wholesale safely, buy FDA-licensed, U.S.-labeled product only from the manufacturer or a distributor that is licensed and authorized to sell it. FDA's 2024 counterfeit alert reminded providers that federal law requires those who dispense or administer prescription drugs to buy them from authorized sources. Seven botulinum toxins are FDA-licensed, none can be compounded, and every delivery is worth a lot-number and packaging check. Who may inject is a separate, state-level question.

Buy Botox wholesale: the rule that matters most

FDA's guidance to purchasers is plain: prescription drugs should be bought only from wholesale distributors that hold a valid U.S. license and are authorized by law (FDA: check distributor licensure). For toxins, the stakes are high. In April 2024, FDA reported counterfeit Botox found in multiple states and given to consumers for cosmetic purposes. It said the incidents involved injections by licensed and unlicensed individuals and/or in non-medical or unlicensed settings, and that it was aware of adverse events, including hospitalizations (FDA counterfeit Botox alert).

Botulinum toxins are also biologics. FDA's 2018 guidance on biological products says products licensed under section 351 of the PHS Act are not eligible for the 503A or 503B compounding exemptions. There is no lawful "compounded Botox" or pharmacy-made substitute.

The FDA-approved botulinum toxins list

As of FDA's September 22, 2026 data, Drugs@FDA lists seven botulinum toxin biologics, all prescription-only (type A records; type B record):

Indications differ by product, so check each label before ordering for aesthetic use. A toxin licensed after September 22, 2026 would appear in FDA's Purple Book. Brand names are trademarks of their owners; MedGrid is not affiliated with any toxin manufacturer.

Counterfeit Botox: what FDA found in 2024

FDA posted its counterfeit Botox alert on April 16, 2024 and updated it May 1, 2024, working with CDC, state health departments and manufacturers. Reported symptoms after injection included blurred or double vision, difficulty swallowing, shortness of breath and weakness. FDA listed these signs of the counterfeit:

• Lot number C3709C3 on the carton and vial.
• The carton names the active ingredient as "Botulinum Toxin Type A" instead of "OnabotulinumtoxinA."
• A 150-unit vial, which FDA says is not a unit size made by AbbVie or Allergan.
• Carton language that is not English.

Where do med spas buy Botox? Channels compared

Every lawful channel ends in the same place: FDA-licensed, U.S.-labeled product from an authorized source. The channels differ in how you buy, not in what you get.

On MedGrid, neuromodulator listings come only from vendors that have cleared per-category document diligence, and each product page shows the vendor's licences and documents, marked verified by MedGrid. Browse the vendor storefronts to see who sells what.

How to check a distributor before the first order

1. State license. FDA's first step is to check the state licensing website for the state where the distributor does business.
2. FDA annual reporting. The second is to check FDA's database of annual reports from wholesale distributors and third-party logistics providers.
3. Brand authorization. Ask the manufacturer whether the distributor is authorized for its product. A licensed distributor still needs a legitimate source.
4. Price sanity. FDA's "Beware of Offers Too Good to be True" flyer warns that aggressive marketing and deep discounts may signal stolen, counterfeit, substandard or unapproved product.

How to check lot numbers and packaging when Botox arrives

A receiving check takes a minute per carton. FDA's "Caution! Check the signs" flyer lists these warning signs for any prescription drug:

• The label is not in English.
• The packaging looks slightly different from the FDA-approved product.
• The product name differs from the FDA-approved name.
• The dosing recommendations are unfamiliar, or safety information and warnings are missing.
• The dosage form or administration is different.

Record the lot number and expiration date of every vial you receive, and compare lots against FDA alerts. If anything doesn't match, quarantine the product, contact the manufacturer and report it to FDA through MedWatch.

Pre-diluted or pre-filled toxin offers

The same 2018 FDA guidance explains that diluting, mixing or repackaging a licensed biologic outside its approved labeling creates an unlicensed biological product. It describes narrow conditions under which FDA doesn't intend to act when a state-licensed pharmacy, federal facility or outsourcing facility does this, starting from the licensed product. Drawing up or diluting a dose at the point of care for immediate administration to a single patient is outside that concern. An outsourcing facility repackaging under the guidance labels the product with its own name, a "Not for resale" statement and its own lot number. A syringe of "toxin" with none of that is a red flag.

Records worth keeping

• Invoices showing the seller's name and address.
• The date you checked the distributor's state license and FDA annual report, and what you found.
• Any written confirmation from the manufacturer that the distributor is authorized.
• Lot numbers and expiration dates for each vial received and used.

Import Alert 66-41 and foreign-labeled toxins

Import Alert 66-41 lets FDA detain unapproved new drugs promoted in the U.S. without physical examination. Its red list has included a foreign firm offering botulinum toxin type A and B products. A toxin shipped from abroad, labeled for another market, is not the FDA-licensed product, whatever it is called.

Who may inject is a state question

Buying from an authorized source doesn't settle who may administer the product. States decide whether RNs may inject, what supervision applies and whether a prior exam is required. See the sourced injectables delegation map and the neuromodulator regulations page. If your practice needs a medical director, MedGrid MSO matches practices with physicians.

Sources

• FDA (openFDA), Drugs@FDA records for botulinum toxin type A products (Botox, Dysport, Xeomin, Jeuveau, Daxxify, Letybo) (2026-09-22)
• FDA (openFDA), Drugs@FDA record for botulinum toxin type B (Myobloc, BLA 103846) (2026-09-22)
• FDA, Counterfeit Version of Botox Found in Multiple States (2024-05-02)
• FDA, Check Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers (2026-03-06)
• FDA, Caution! Check for these signs that a prescription drug may be unsafe, ineffective, or fake (Know Your Source flyer) (2026-09-23)
• FDA, Beware of Offers Too Good to be True (Know Your Source flyer) (2026-09-23)
• FDA, Import Alert 66-41: Detention Without Physical Examination of Unapproved New Drugs Promoted in the U.S. (2026-09-23)
• FDA (CDER/CBER), Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application, Guidance for Industry (2018-01-01)

Frequently asked questions

Where do med spas buy Botox?

Through the manufacturer's own ordering channel where one exists, through licensed distributors the manufacturer authorizes, or through marketplaces whose vendors are licensed and verified. Whatever the channel, FDA's position is that providers who administer prescription drugs must buy them from authorized sources.

How can I tell if Botox is counterfeit?

FDA's 2024 alert listed lot C3709C3, cartons reading 'Botulinum Toxin Type A' instead of 'OnabotulinumtoxinA', 150-unit vials (not a size AbbVie or Allergan makes) and non-English packaging. FDA's general warning signs include packaging that looks slightly different, an unfamiliar product name and missing safety information. Quarantine anything suspicious and report it to FDA MedWatch.

Which botulinum toxins are FDA-approved?

As of FDA's September 22, 2026 data, seven: Botox and Botox Cosmetic, Dysport, Xeomin, Jeuveau, Daxxify, Letybo and Myobloc. All are prescription biologics. A later approval would appear in FDA's Purple Book.

Can Botox be compounded?

No. Botulinum toxins are biological products licensed under section 351 of the PHS Act, and FDA's guidance says such products are not eligible for the 503A or 503B compounding exemptions. The lawful product is the FDA-licensed, U.S.-labeled one.

Is it legal to buy Botox from overseas suppliers?

Foreign-labeled or unapproved toxins are a known enforcement target. FDA's Import Alert 66-41 lets it detain unapproved new drugs promoted in the U.S. without physical examination, and its red list has included a foreign firm offering botulinum toxin products. FDA's counterfeit alert also listed non-English packaging as a warning sign.

This article is general information, not legal advice. Purchasing, delegation and supervision rules vary by state; confirm with your boards and counsel.

Check the rules, then see what verified vendors list. Review neuromodulator rules for your state in the MedGrid regulations tool, and verify your NPI to see wholesale pricing from diligence-cleared vendors. Sign-up is free.